6th Annual Atlanta Lung Cancer Symposium Slides
Plenary Session 1
Molecular Predictors of Response and Survival in NSCLC
Gerold Bepler, MD, PhD
Non-Invasive Strategies: Optimizing the Staging of NSCLC
Thomas A. D’Amico MD
New Developments in Neoadjuvant Therapy in NSCLC
Katherine M.W. Pisters, MD
Medical Session 1
Integration of Targeted Therapies in Early Stage Non-Small Cell Lung Cancer
Mark G Kris, MD
Therapeutic Implications of Genomics in Early Stage NSCLC
Anil Potti, MD
Present and Future of Adjuvant Therapy in Early Stage NSCLC
Heather Wakelee, MD
Medical Session 2
Chemo-Beamo: Is it for Real or Just a Dreamo?
Walter J Curran, Jr, MD
Surgery for Stage IIIA Non-small Cell Lung Cancer
Daniel L. Miller MD
Medical Session 3
Small Cell Lung Cancer: Progress or Status Quo?
Nasser H. Hanna, MD
New Frontiers in Antiangiogenic Therapy in NSCLC
John Heymach, MD, PhD
Indications for First Line EGFR TKI in Advanced NSCLC
Pasi A. Jänne, MD, PhD
Emerging Novel A Treatment of Lung Cancer
Fadlo Raja Khuri, MD
Medical Session 4
Beyond First-Line Therapy in NSCLC: Timing and Choices
Edward S. Kim, MD
Management of EGFR TKI Failures, in the Salvage Setting
William Pao, MD, PhD
Medical Session 5
Cetuximab-based Treatment of Advanced Non-small Cell Lung Cancer
Rodolfo E. Bordoni, MD
Development and Integration of HDAC Inhibitors, Aurora Kinase Inhibitors, and
Anti-IGF-1R Management of Advanced NSCLC
Taofeek K. Owonikoko, MD, PhD
Plenary Session 2
Optimizing Lung Cancer Care in Special Populations: Focus on Racial and Ethnic Disparities
Otis W. Brawley, MD
Surgical Session 1
Thoracoscopic Lobectomy: Oncologic Outcomes
Thomas A. D’Amico MD
Fundamentals of VATS Lobectomy
William R. Mayfield, MD, FACS and Ward V. Houck, MD, FACS
Transition from Postero-Lateral Thoracotomy to VATS Lobectomy
William R. Mayfield, MD, FACS
Peri-Operative VATS Lobectomy Outcomes
Daniel L Miller MD
Surgical Session 2
Seeing Beyond the Optical Reach of the Bronchoscope. Advanced Endoscopy Techniques
Rabih Bechara, MD
Robotic Lobectomy: Current Status
Raja M Flores MD
Severe COPD (or Emphysema) Does Not Increase Post-Operative Risk nor Decrease Long Term Survival In Patients with NSCLC: The Impact of Thoracoscopy
John R. Roberts MD, MBA
Surgical Session 3
Lung Cancer Radiosurgery: The Role of Pulmonologists and Thoracic Surgeons
Mark P. McLaughlin, MD
Radiofrequency Ablation of Inoperable Lung Cancers
Robert Suh, MD
Questions?
Please contact Jackie Falconer at jfalconer@educationalconcepts.net
|
This activity is sponsored by |

|
In association with: |

|
 |
 |
GASCO, Georgia Cancer Coalition, and Georgia CORE did not receive compensation in
any form for this educational symposium |
| |
This activity is supported by educational grants from:
Covidien, Genentech BioOncology
& OSI Oncology, and Lilly USA, LLC |
|